TrialClinical pharmacokinetics2010

Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects.

Silke Retlich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.